Target intelligence / Profile preview

Louse exoskeleton

Molecular classification
Other
01

Overview

The louse exoskeleton is a multilayered external structure primarily composed of chitin (a polysaccharide) and diverse cuticular proteins. In lice, as in other insects, it provides rigidity, mechanical support, protection against desiccation, and serves as the interface for interaction with the environment[1][4]. Key structural proteins identified in the head louse nit sheath (the protective covering of louse eggs) include louse nit sheath protein 1 (LNSP1) and louse nit sheath protein 2 (LNSP2), with high content of glycine, glutamine/glutamic acid, alanine, and valine residues[2][3]. Protein cross-linking (mediated by enzymes like transglutaminase) and sclerotization processes further harden and strengthen the exoskeleton[1][4]. Chemically, the exoskeleton's cuticle is a composite of chitin polymers and structural proteins; regions can be further stiffened by sclerotization (protein cross-linking) or, in other arthropods, biomineralization—but in lice it is almost purely organic with minimal mineralization[4]. Unlike classical drug targets, therapies for lice infestations act by physically or chemically compromising the integrity of the exoskeleton, rather than targeting a specific molecular entity[1][4]. "Louse exoskeleton" does not represent a discrete, canonical molecular target; it is an anatomical and functional barrier composed of biopolymers and proteins, essential for louse survival but not a target in the conventional pharmacological sense.

Other names
Head louse exoskeletonBody louse cuticleLouse cuticle
02

Mechanism of action

Physically disrupts or penetrates the exoskeleton to kill lice (e.g., by blocking spiracles causing asphyxiation, dissolving or disrupting the cuticle, or inhibiting neural function through action on the nervous system after penetrating the exoskeleton)

03

Biological functions

ProtectionPrevention of desiccationStructural supportMechanical barrier
04

Disease associations

lice infestations
05

Safety considerations

Potential for skin irritation or allergic reactions from treatments that target the exoskeletonResistance development when insecticidal agents cannot penetrate or disrupt the exoskeleton effectively
06

Interacting drugs

Permethrin

3 more in the full profile.

Beyond the preview

Go deeper on Louse exoskeleton.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Louse exoskeleton.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call